% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @INBOOK{Zafar:145422, author = {Zafar, Saima and Noor, Aneeqa and Zerr, Inga}, title = {{C}hapter 4 - {T}herapies for prion diseases}, volume = {165}, publisher = {Elsevier}, reportid = {DZNE-2020-00765}, pages = {47 - 58}, year = {2019}, comment = {Handbook of Clinical Neurology}, booktitle = {Handbook of Clinical Neurology}, abstract = {Recent advances in understanding of the molecular biology of prion diseases and improved clinical diagnostic techniques might allow researchers to think about therapeutic trials in Creutzfeldt–Jakob disease (CJD) patients. Some attempts have been made in the past and various compounds have been tested in single case reports and patient series. Controlled trials are rare. However, in the past few years, it has been demonstrated that clinical trials are feasible. The clinicians might face several specific problems when evaluating the efficacy of the drug in CJD, such as rareness of the disease, lack of appropriate preclinical tests and heterogeneous clinical presentation in humans. These problems have to be carefully addressed in future.}, cin = {Ext UMG Zerr / Göttingen Pre 2020 / AG Zerr}, cid = {I:(DE-2719)5000037 / I:(DE-2719)6000014 / I:(DE-2719)1440011-1}, pnm = {344 - Clinical and Health Care Research (POF3-344)}, pid = {G:(DE-HGF)POF3-344}, typ = {PUB:(DE-HGF)7}, url = {https://pub.dzne.de/record/145422}, }